BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 37075222)

  • 1. Regional spreading pattern is associated with clinical phenotype in amyotrophic lateral sclerosis.
    Maranzano A; Verde F; Colombo E; Poletti B; Doretti A; Bonetti R; Gagliardi D; Meneri M; Maderna L; Messina S; Corti S; Morelli C; Silani V; Ticozzi N
    Brain; 2023 Oct; 146(10):4105-4116. PubMed ID: 37075222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spreading in ALS: The relative impact of upper and lower motor neuron involvement.
    Gromicho M; Figueiral M; Uysal H; Grosskreutz J; Kuzma-Kozakiewicz M; Pinto S; Petri S; Madeira S; Swash M; de Carvalho M
    Ann Clin Transl Neurol; 2020 Jul; 7(7):1181-1192. PubMed ID: 32558369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncovering amyotrophic lateral sclerosis phenotypes: clinical features and long-term follow-up of upper motor neuron-dominant ALS.
    Sabatelli M; Zollino M; Luigetti M; Grande AD; Lattante S; Marangi G; Monaco ML; Madia F; Meleo E; Bisogni G; Conte A
    Amyotroph Lateral Scler; 2011 Jul; 12(4):278-82. PubMed ID: 21702734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focal thinning of the motor cortex mirrors clinical features of amyotrophic lateral sclerosis and their phenotypes: a neuroimaging study.
    Schuster C; Kasper E; Machts J; Bittner D; Kaufmann J; Benecke R; Teipel S; Vielhaber S; Prudlo J
    J Neurol; 2013 Nov; 260(11):2856-64. PubMed ID: 23996101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential motor neuron involvement in progressive muscular atrophy: a comparative study with amyotrophic lateral sclerosis.
    Riku Y; Atsuta N; Yoshida M; Tatsumi S; Iwasaki Y; Mimuro M; Watanabe H; Ito M; Senda J; Nakamura R; Koike H; Sobue G
    BMJ Open; 2014 May; 4(5):e005213. PubMed ID: 24833696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Spectrum of Amyotrophic Lateral Sclerosis (ALS).
    Grad LI; Rouleau GA; Ravits J; Cashman NR
    Cold Spring Harb Perspect Med; 2017 Aug; 7(8):. PubMed ID: 28003278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of symptom development in patients with motor neuron disease.
    Walhout R; Verstraete E; van den Heuvel MP; Veldink JH; van den Berg LH
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Feb; 19(1-2):21-28. PubMed ID: 29037065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deciphering amyotrophic lateral sclerosis: what phenotype, neuropathology and genetics are telling us about pathogenesis.
    Ravits J; Appel S; Baloh RH; Barohn R; Brooks BR; Elman L; Floeter MK; Henderson C; Lomen-Hoerth C; Macklis JD; McCluskey L; Mitsumoto H; Przedborski S; Rothstein J; Trojanowski JQ; van den Berg LH; Ringel S
    Amyotroph Lateral Scler Frontotemporal Degener; 2013 May; 14 Suppl 1(0 1):5-18. PubMed ID: 23678876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential involvement of corticospinal tract (CST) fibers in UMN-predominant ALS patients with or without CST hyperintensity: A diffusion tensor tractography study.
    Rajagopalan V; Pioro EP
    Neuroimage Clin; 2017; 14():574-579. PubMed ID: 28337412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional limitation of the masticatory system in patients with bulbar involvement in amyotrophic lateral sclerosis.
    Riera-Punet N; Martinez-Gomis J; Willaert E; Povedano M; Peraire M
    J Oral Rehabil; 2018 Mar; 45(3):204-210. PubMed ID: 29240971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A susceptibility-weighted imaging qualitative score of the motor cortex may be a useful tool for distinguishing clinical phenotypes in amyotrophic lateral sclerosis.
    Conte G; Sbaraini S; Morelli C; Casale S; Caschera L; Contarino VE; Scola E; Cinnante C; Trogu F; Triulzi F; Silani V
    Eur Radiol; 2021 Mar; 31(3):1281-1289. PubMed ID: 32886203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortical thickness in ALS: towards a marker for upper motor neuron involvement.
    Walhout R; Westeneng HJ; Verstraete E; Hendrikse J; Veldink JH; van den Heuvel MP; van den Berg LH
    J Neurol Neurosurg Psychiatry; 2015 Mar; 86(3):288-94. PubMed ID: 25121571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and outcomes of clinical phenotypes in amyotrophic lateral sclerosis/motor neuron disease: Australian National Motor Neuron Disease observational cohort.
    Talman P; Duong T; Vucic S; Mathers S; Venkatesh S; Henderson R; Rowe D; Schultz D; Edis R; Needham M; Macdonnell R; McCombe P; Birks C; Kiernan M
    BMJ Open; 2016 Sep; 6(9):e012054. PubMed ID: 27694488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS.
    Gordon PH; Cheng B; Katz IB; Mitsumoto H; Rowland LP
    Neurology; 2009 Jun; 72(22):1948-52. PubMed ID: 19487653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study.
    Chiò A; Calvo A; Moglia C; Mazzini L; Mora G;
    J Neurol Neurosurg Psychiatry; 2011 Jul; 82(7):740-6. PubMed ID: 21402743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dominant Heterogeneity of Upper and Lower Motor Neuron Degeneration to Motor Manifestation of Involved Region in Amyotrophic Lateral Sclerosis.
    Jin J; Hu F; Zhang Q; Chen Q; Li H; Qin X; Jia R; Kang L; Dang Y; Dang J
    Sci Rep; 2019 Dec; 9(1):20059. PubMed ID: 31882886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Motor-evoked potentials in amyotrophic lateral sclerosis: potential implications in detecting subclinical UMN involvement in lower motor neuron phenotype.
    Zoccolella S; Mastronardi A; Scarafino A; Iliceto G; D'Errico E; Fraddosio A; Tempesta I; Morea A; Scaglione G; Introna A; Simone IL
    J Neurol; 2020 Dec; 267(12):3689-3695. PubMed ID: 32676769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Switchboard" malfunction in motor neuron diseases: Selective pathology of thalamic nuclei in amyotrophic lateral sclerosis and primary lateral sclerosis.
    Chipika RH; Finegan E; Li Hi Shing S; McKenna MC; Christidi F; Chang KM; Doherty MA; Hengeveld JC; Vajda A; Pender N; Hutchinson S; Donaghy C; McLaughlin RL; Hardiman O; Bede P
    Neuroimage Clin; 2020; 27():102300. PubMed ID: 32554322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyotrophic Lateral Sclerosis Regional Variants (Brachial Amyotrophic Diplegia, Leg Amyotrophic Diplegia, and Isolated Bulbar Amyotrophic Lateral Sclerosis).
    Jawdat O; Statland JM; Barohn RJ; Katz JS; Dimachkie MM
    Neurol Clin; 2015 Nov; 33(4):775-85. PubMed ID: 26515621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Objective markers for upper motor neuron involvement in amyotrophic lateral sclerosis].
    Iwata NK
    Brain Nerve; 2007 Oct; 59(10):1053-64. PubMed ID: 17969345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.